[1]
Zaman, Z.A. and Sinha, H.K. 2017. Comparative study of efficacy and adverse effects profile of azilsartan, olmesartan and candesartan in the control of essential hypertension. International Journal of Basic & Clinical Pharmacology. 6, 9 (Aug. 2017), 2140–2144. DOI:https://doi.org/10.18203/2319-2003.ijbcp20173733.